Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00418704

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Site 12 Aix-en-Provence, France

Site 22 Beauvais, France

Site 30 Charleville-Mézières, France

Site 48 Clermont-Ferrand, France

View all 22 locations

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer

NCT00084981

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

NCT01086254

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sanofi-Aventis Investigational Site Number 250002 Caen, France

Sanofi-Aventis Investigational Site Number 250003 Marseille, France

Sanofi-Aventis Investigational Site Number 250004 Toulouse, France

Sanofi-Aventis Investigational Site Number 250001 Villejuif, France

View all 14 locations

View Trial Details

Completed

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00072072

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00079287

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: Nagoya University Hospital Aichi, Japan

Asahikawa Medical College Asahikawa, Japan

National Cancer Center Hospital East Chiba-ken, Japan

National Hospital Organization - Ehime National Hospital Ehime, Japan

View all 24 locations

View Trial Details

Completed

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer

NCT00970580

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Resesarch Site Los Angeles, California, United States

Resesarch Site San Diego, California, United States

Resesarch Site Denver, Colorado, United States

View Trial Details

Completed

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00022308

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: South Jersey Regional Cancer Center Millville, New Jersey, United States

Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States

Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States

Community Medical Center Toms River, New Jersey, United States

View Trial Details

Completed

Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)

NCT01368848

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III Salzburg, State of Salzburg, Austria

Univ.-Klinik für Innere Medizin V Innsbruck, Abteilung für Hämatologie und Onkologie Innsbruck, Tyrol, Austria

Landeskrankenhaus Feldkirch Feldkirch, Vorarlberg, Austria

View Trial Details

Completed

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

NCT00014456

Conditions: AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +100 more
Locations: Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions